tetano
Editor, Senior Moderator
Int J Clin Pract
. 2020 Oct 27;e13792.
doi: 10.1111/ijcp.13792. Online ahead of print.
Can Tenofovir diphosphate be a candidate drug for Sars-Cov2? First clinical perspective
Omer Kutlu[SUP] 1 [/SUP]
Affiliations
Abstract
COVID-19 pandemic continues to spread across the world in late August 2020. To date, total cases of COVID-19 exceed 24.5 million including 833.556 deaths according to the WHO data. Governments still taking numerous measures to prevent the spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The estimate for the basic reproduction number during the early stages of the COVID-19 outbreak is recently reported as 4.22 ? 1.69 in Europe that shows COVID-19 has a high transmission rate.
. 2020 Oct 27;e13792.
doi: 10.1111/ijcp.13792. Online ahead of print.
Can Tenofovir diphosphate be a candidate drug for Sars-Cov2? First clinical perspective
Omer Kutlu[SUP] 1 [/SUP]
Affiliations
- PMID: 33108703
- DOI: 10.1111/ijcp.13792
Abstract
COVID-19 pandemic continues to spread across the world in late August 2020. To date, total cases of COVID-19 exceed 24.5 million including 833.556 deaths according to the WHO data. Governments still taking numerous measures to prevent the spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The estimate for the basic reproduction number during the early stages of the COVID-19 outbreak is recently reported as 4.22 ? 1.69 in Europe that shows COVID-19 has a high transmission rate.